Search - tctmd.com

Displaying 241 - 260 of 1724

Sort: Relevancy | Date

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Daily News

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Yael L. Maxwell

November 13, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Daily News

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

Todd Neale

October 29, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Industry News

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

October 09, 2019

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Caitlin E. Cox

October 08, 2019

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Presentation TCT Abstracts Posters 2019

A Meta-analysis of Percutaneous Coronary Intervention in Small Vessel Coronary Artery Disease using Drug-coated Balloon versus Drug-coated Stent

Presenter: Kifah Hussain

September 29, 2019

Presentation TCT Abstracts Posters 2019

Causes and predictors of 6-month readmission rate after drug eluting stent in the contemporary era- A nationwide analysis

Presenter: Syed Zaid

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Marcus A. Banks

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

Advertisement

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

CTO PCI: Lower Success, More Complications vs Other Complex PCI

TCTMD’s Top 10 Most Popular Stories for October 2019

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

Repeat Target-Lesion PCI: An Option for Public Reporting?

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

A Meta-analysis of Percutaneous Coronary Intervention in Small Vessel Coronary Artery Disease using Drug-coated Balloon versus Drug-coated Stent

Causes and predictors of 6-month readmission rate after drug eluting stent in the contemporary era- A nationwide analysis

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content